Medicamen Biotech has informed that the Meeting of the Board of Directors of the Company will be held on November 13, 2014, to consider & to take on record the Unaudited Quarterly Results for the Second Quarter & half year ended on September 30, 2014. Further, as per the Company’s Code of conduct for Prevention of Insider Trading and corporate disclosure practices adopted pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the trading window for dealing in the securities of the Company is closed for the Company’s Directors /Officers and designated employees of the Company from November 06, 2014 and would open 24 hours after the announcement of financial results to the public.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: